$13.5M
The Series B round features participation from Amadeus Capital Partners and Octopus Investments.
TrialReach provides a digital platform that aggregates global clinical trial data to connect patients and medical researchers.
TrialReach provides a digital platform that aggregates global clinical trial data to connect patients and medical researchers. Founded in 2010, the company operates in London.

Pablo Graiver
CEO
Pablo brings digital health and clinical trials experience from leadership roles at TrialReach, Drumroll AI, and Antidote.me, alongside strategy and M&A experience at IQVIA.
The Series B round features participation from Amadeus Capital Partners and Octopus Investments.